Liver International, Volume 46, Issue 5, May 2026.ABSTRACT Strong non‐invasive tests (NITs) are needed to predict decompensation in patients with compensated advanced chronic liver disease (cACLD) and improve personalized patient care. We conducted a comprehensive review of the studies evaluating the effectiveness of NITs in predicting decompensation or liver‐related death in patients with cACLD.
Audrey Payancé +5 more
wiley +1 more source
Effect of TIMPs and their minimally engineered variants in blocking invasion and migration of brain cancer cells. [PDF]
OncotargetTaheri E, Raeeszadeh-Sarmazdeh M.
europepmc +1 more source
Matrix Metalloproteinases in Hepatocellular Carcinoma: Mechanistic Roles and Emerging Inhibitory Strategies for Therapeutic Intervention. [PDF]
Cancers (Basel)Dimesa AM, Coban MA, Shoari A.
europepmc +1 more source
Advances in targeting myocardial fibrosis: integrating mechanisms and therapeutics. [PDF]
Front Cardiovasc MedXu Z, Zhao Y.
europepmc +1 more source
Matrix metalloproteinases and their tissue inhibitors as upcoming biomarker signatures of connective tissue diseases-related interstitial lung disease: towards an earlier and accurate diagnosis. [PDF]
Mol MedPulito-Cueto V +9 more
europepmc +1 more source
Comparison of microcurrent and low level laser therapy on matrix metalloproteinases and tissue inhibitors of metalloproteinases expressions in surgical wound healing. [PDF]
Sci RepEl Makakey AM +6 more
europepmc +1 more source
Spotlight on Proteases: Roles in Ovarian Health and Disease. [PDF]
CellsKushawaha B, Pelosi E.
europepmc +1 more source
Matrix Metalloproteinase-13 Is an Unfavorable Prognostic Factor in Chordoma by Digesting Growth Inhibitory Collagens. [PDF]
Cancer MedOishi Y +6 more
europepmc +1 more source
Kidney Transplant Recipients with Acute Antibody-Mediated Rejection Show Altered Levels of Matrix Metalloproteinases and Their Inhibitors: Evaluation of Circulating MMP and TIMP Profiles. [PDF]
Int J Mol SciVázquez-Toledo MA +10 more
europepmc +1 more source